News
-
AMR teamwork call
Tuesday | Dec 6 2016PHARMACISTS are being asked to work together with GPs, nurses and allied healthcare professionals in the global fight against antimicrobial resistance (AMR).
-
Communities unaware of pharmacy services
Tuesday | Dec 6 2016DESPITE the wide range of potential healthcare options available through their local community pharmacist, 87% of Australians are seeking first line treatment from their general practitioner, seemingly unaware of other options, according to research released by Sanofi Consumer Healthcare last week.
-
CW satisfies again
Tuesday | Dec 6 2016THE latest customer satisfaction ratings from Roy Morgan Research have seen Chemist Warehouse regain second position in the pharmacy category for Oct.
-
Blackmores markets
Tuesday | Dec 6 2016BLACKMORES is hosting a Christmas Twilight Charity Market this Thu 08 Dec from 3.30pm at its Sydney campus in Warriewood.
-
Patient-based funding push
Tuesday | Dec 6 2016THE Society of Hospital Pharmacists has reiterated its position that funding for services provided by pharmacists should be patient-centred, and strive towards better health outcomes.
-
Dispensary Corner 5 Dec 16
Monday | Dec 5 2016NSW high profile pharmacist and tweeter Rick Samimi, also a National Councillor for the Pharmacy Guild.
-
Weekly Comment 05 Dec 16: Driving business performance
Monday | Dec 5 2016WELCOME to PD's weekly comment feature.
-
Shortages resolved
Monday | Dec 5 2016THE Therapeutic Goods Administration has advised that a shortage of ampicillin injection and amoxycillin injection, first flagged in May 2015, has now been resolved.
-
FDA Jardiance tick
Monday | Dec 5 2016THE US Food and Drug Administration has approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes and cardiovascular disease.
-
Hep C tops the $ list
Monday | Dec 5 2016THE annual release of the Australian Prescriber's top ten subsidised drugs in Australia for 2015-16 has seen the new hepatitis C listed drugs taking the very high profile position as highest cost to government, in spite of relatively low patient numbers compared to the script number rankings.